Alpha-2-adrenergic agonists for treating presbyopia

Details Alpha-2-adrenergic agonists for treating presbyopia Alpha-2-adrenergic agonists for treating presbyopia

A - Human Necessities

61

K

A61K 31/55 (2006.01) A61K 31/00 (2006.01) A61K 31/135 (2006.01) A61K 31/155 (2006.01) A61K 31/165 (2006.01) A61K 31/415 (2006.01) A61K 31/42 (2006.01) A61K 31/54 (2006.01)

Patent

CA 2137285

2137285 9325199 PCTABScor01 This invention is directed to treatment for increasing the accommodative ability of the eye, for the purpose of decreasing the severity of clinically evident presbyopia, an age-related loss of accommodative ability. The compounds and methods of the invention act by decreasing the tone of parts of the ciliary muscle which act to decrease accommodation, thereby increasing the contractile force of the remaining ciliary muscle, with resultant increased accommodative function.

Affiliated with

Also associated with

Rating

Alpha-2-adrenergic agonists for treating presbyopia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alpha-2-adrenergic agonists for treating presbyopia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-2-adrenergic agonists for treating presbyopia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1920188